Magdalena Jonikas

Partner at Syncona Limited

Magdalena Jonikas is a highly accomplished professional in the pharmaceutical and biotechnology industry. She currently serves as a Board Director at Mosaic TX, a role she has held since at least September 2022.1 2

Professional Experience

Magdalena holds several key positions:

Board Director at Mosaic TX1 4
Board Director at Kesmalea Therapeutics1 2
Lead Partner at Syncona Investment Management Limited2
Board member at OMass Therapeutics2

Previously, she worked as an Associate Partner at McKinsey & Company, specializing in pharmaceuticals Research & Development, portfolio management, and Business Development and Licensing.1 2

Educational Background

Magdalena has a strong academic foundation in bioengineering:

PhD in Bioengineering from Stanford University1 4
MS and BSE degrees also from Stanford University1
Postdoctoral fellowship at Harvard Medical School's Computational Health Informatics Programme2

Industry Involvement

Magdalena plays a significant role in the development of innovative therapeutics companies. For instance, she was involved in Mosaic Therapeutics' $28 million Series A funding round, where she commented on the company's potential to provide unprecedented insights for developing targeted therapies.3

Her LinkedIn profile (username: magdalena-jonikas-63580a3) likely contains more detailed information about her professional journey and accomplishments in the biotechnology sector.4